Graybug Vision Inc - ESG Rating & Company Profile powered by AI
Alternative corporations in the scoring industry group for Graybug Vision Inc are displayed. This webpage displays a zero-cost Sustainability assessment covering Graybug Vision Inc. The Disclosure rating includes 17 United Nations Sustainable Development Goals including: 'Affordable & Clean Energy', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'.
Graybug Vision Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Graybug Vision Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Graybug Vision Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Graybug Vision Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Graybug Vision Inc report the average age of the workforce?
Sign up for free to unlockDoes Graybug Vision Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Graybug Vision Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Graybug Vision Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Graybug Vision Inc offer flexible work?
Sign up for free to unlockDoes Graybug Vision Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Graybug Vision Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Graybug Vision Inc conduct supply chain audits?
Sign up for free to unlockDoes Graybug Vision Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Graybug Vision Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Graybug Vision Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Graybug Vision Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Graybug Vision Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Graybug Vision Inc disclose water use targets?
Sign up for free to unlockDoes Graybug Vision Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Graybug Vision Inc have a product recall in the last two years?
Sign up for free to unlockDoes Graybug Vision Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Graybug Vision Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Graybug Vision Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Graybug Vision Inc disclose parental leave metrics?
Sign up for free to unlockDoes Graybug Vision Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Graybug Vision Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Graybug Vision Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Graybug Vision Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Graybug Vision Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Graybug Vision Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Graybug Vision Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Graybug Vision Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Graybug Vision Inc disclose its waste policy?
Sign up for free to unlockDoes Graybug Vision Inc report according to TCFD requirements?
Sign up for free to unlockDoes Graybug Vision Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Graybug Vision Inc disclose energy use targets?
Sign up for free to unlockDoes Graybug Vision Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Graybug Vision Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Graybug Vision Inc
These potential risks are based on the size, segment and geographies of the company.
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.